Research Paper Volume 14, Issue 1 pp 368—388

LINC02362 attenuates hepatocellular carcinoma progression through the miR-516b-5p/SOSC2 axis


Figure 1. LINC02362 is correlated with a favorable prognosis of HCC patients. (A) Differential analyses of LINC02362 levels in non-tumor (NT; n=50) or HCC tissues (n=369). (B, C) Kaplan-Meier plots showing the overall survival (OS; B) or disease-free interval (DFI; C) of HCC patients stratified by LINC02362 levels. (DI) The analyses of expression of LINC02362 in HCC patients with serum alpha feto-protein (AFP)-negative or positive (D), different Child-Pugh grades (E), histological grades (F), living status (G), vascular invasion (H) or TNM stages (I). *0.01 < P < 0.05, **0.001 < P < 0.01, ***0.0001 < P < 0.001. NS, not significant.